A Study on the Role of Female Investors' Perspective in Promoting the Innovation and Development of Rare Diseases

Rare diseases, affecting over 300 million patients globally, pose a significant public health challenge. These diseases have long faced challenges in terms of insufficient innovation resource allocation and inadequate investment support. Traditional investment models, characterized by their focus on short-term gains and risk aversion, struggle to meet the unique demands of the rare disease sector, which is marked by high risk, long cycles, and low commercial returns. Female investors, with their unique value concepts and investment behaviors, are becoming a crucial force in driving the innovative development of rare diseases. This study analyzes the behavioral patterns, value creation mechanisms, and practical approaches of female investors in rare disease investments, systematically explaining how they can inject new vitality into the rare disease innovation ecosystem through their socially responsible investment motives, long-term value-oriented strategies, and humanistic care influenced by emotional factors. The research finds that female investors exhibit unique methods of financial support, outstanding resource integration capabilities, and comprehensive value-added services, effectively addressing the shortcomings of traditional investment models in patient needs, social value creation, and sustainable development. However, female investors still face market-level issues such as funding scale limitations, insufficient decision-making influence, and professional skepticism, as well as policy environment constraints like inadequate regulatory policies and missing tax incentives, and social cognitive limitations. This study proposes systematic strategic recommendations for enhancing market capabilities, optimizing the policy environment, and improving social cognition, providing theoretical guidance and practical references to help female investors better play a promoting role.